LivingGLP1
Study S000270

Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors

Registration

Registration
NCT07095517
Acronym
PROSPECT
Study type
INTERVENTIONAL
Phase
PHASE1
Masking
NONE
Status
RECRUITING
Enrollment
20
Start
2026-02-24
Primary completion
2027-03-31
Lead sponsor
Massachusetts General Hospital
Conditions
Colorectal Cancer Prevention; Colorectal Adenoma
Interventions
DRUG:Tirzepatide
Results posted
FALSE
Individual participant data sharing
YES
Secondary identifiers
NIH:1OT2CA297680-01; OTHER_GRANT:CGCATF-2023/100036

Registered primary outcomes

  • Change in Urinary PGE-M [From enrollment to the end of treatment at 24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.